SCHEMBL7224733

SCHEMBL7224733

CC(=NO)OC(=O)[C@@H](N)CCCCNCOC(=O)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.36
DPP7 Q9UHL4 3/20 0.36
DPP8 Q6V1X1 2/20 0.36
DPP9 Q86TI2 1/20 0.36
SLC1A5 Q15758 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ADRB2 P07550 2/20 0.34
ADRB1 P08588 2/20 0.34
ADRB3 P13945 2/20 0.34
SLC6A3 Q01959 2/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34
SCN1A P35498 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
TSHR P16473 1/20 0.33
SLC7A5 Q01650 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219500 0.81 DPP7 (0.31) DPP7TSHR
SCHEMBL7220597 0.79 NOS3 (0.31)
SCHEMBL7218187 0.79
SCHEMBL7224728 0.78 FOLH1 (0.43) TDP1
SCHEMBL7219144 0.76 ANPEP (0.37) TDP1DPP7LMNAALDH1A1ADRB2
SCHEMBL7908797 0.75 SMN1; SMN2 (0.36) DPP7DPP8ALDH1A1SMN1; SMN2KMT2A
SCHEMBL7911821 0.73 ALDH1A1 (0.38) TDP1DPP7DPP8SLC1A5LMNA
SCHEMBL27675504 0.72 NAAA (0.56) TDP1LMNAALDH1A1SLC6A3HTR1A
SCHEMBL17821459 0.70 LMNA (0.47) TDP1KDM4ELMNAALDH1A1TSHR
SCHEMBL7915415 0.70 DPP8 (0.37) TDP1DPP7DPP8DPP9SLC1A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US disclosed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP disclosed